-
Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1-/-SNCAA53T double mutant mouse model of Parkinson's disease. Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-08 Luisa Franck,Lucie Valek,Lisa Hahnefeld,Sandra Trautmann,Carlo Angioni,Marc-Philipp Weyer,Dominique Thomas,Robert Gurke,Ilka Wittig,Gerd Geisslinger,Irmgard Tegeder
Parkinson's disease (PD) involves α-synuclein (αSyn) oligomerization and aggregation, processes facilitated by glycosphingolipids. Defective glycosphingolipid transport and degradation-especially via the lipid-degrading enzyme glucocerebrosidase 1 (GCase, gene GBA1)-aggravate PD and increase dementia risk. Ambroxol is a mucolytic drug and has emerged as a promising add-on therapy for PD since it acts
-
GluD1 at the synaptic crossroads: from domain structure to circuit dysfunction Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-04 Poojashree B. Chettiar, Shashank M. Dravid
For several decades, the glutamate delta-1 receptor (GluD1) has remained an enigmatic entity among ionotropic glutamate receptors (iGluRs), primarily due to its lack of classical ion channel activity. Recent advancements have redefined GluD1 as a multifunctional synaptic organizer, essential for the development, plasticity, and behavioral regulation of both excitatory and inhibitory circuits. In this
-
AI-driven breakthroughs in ion channel drug discovery: the future is now Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-02 Ming-yue Zheng, Zhao-bing Gao
-
Graph-based deep learning approach for high-throughput protein-DNA interaction scoring Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-01 Yi-hao Zhao, Ying Wang, Chao Shen, De-jun Jiang, Shu-kai Gu, Hui-feng Zhao, Zi-yi You, Ting-jun Hou, Yu Kang
-
Adapter protein 2-modulated $${{{\rm{\mu }}}}$$-opioid receptor trafficking in paraventricular thalamus contributes to fentanyl contextual addiction memory in mice Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-01 Yu-jie Li, Ruo-song Chen, Gui-ying Zan, Ying-cai Song, Xue-ying Huang, Bing Zhang, Wei-jia Du, Ti-fei Yuan, Zhi-qiang Liu
-
Serotonin receptor 4 in the ventral CA3 regulates agomelatine-induced anxiolytic-like behaviors Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-01 Xiang-hu Liu, Muhammad Naveed, Xiao-yun Hu, Lin-lin Zhu, Fan Meng, Qi-gang Zhou, Jing Zhang
-
ATM promotes bone metastatic propensity of breast cancer by inducing osteoclastogenesis via the NFκB-CCL2 pathway Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-01 Ming-yang Qin, Yuan-hui Liu, Ze-liang Wu, Yi Huang, Jiang Wang, Tian Xia, Lin Zhu, Hui Liu, Rong Xu
-
Roles and related underlying mechanisms of mitochondrial RNA modification in cancer progression Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-12-01 Ling-zhi Wang, Tao-yu Yang, Zi-hui Xiong, Jian-xin Peng, Jia-wang Zhou, Hong-sheng Wang, Jun-ming He
-
Resibufogenin ameliorates cerebral ischemia-reperfusion injury by modulating microglial redox homeostasis via Keap1-Nrf2-TFR1/ARE axis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-10 Yao Chen, Wen-qing Shi, Pei Zhang, Ran Wang, Wen-bo Ye, Guo-qiang Lin, Shou-jiao Peng, Jian-ge Zhang
-
Mup3 ameliorates the dysregulation of glucose and lipid metabolism in MAFLD Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-06 Xiao-min Zhang, Jing-ya Gao, Dong Wang, Xiang Wei, Li Lin, Xin-rui Xie, Han Gao, Xiu-yun Wang, Hong-ting Hua, Yong-xia Xu, Lei Zhang, Chao-bing Gao, Hua-bing Zhang
-
Magnolin overcomes EGFR TKI resistance in NSCLC by modulation of NDRG1-NRG2-HECW1 pathway Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-05 Qing Wu, Qi Su, Man Zhu, Tian-feng Yang, Wen-juan Tang, Yu Hu, Jia-yan Ren, Xiu-hong Peng, Su-yu Zhang, Yan-min Zhang
-
Correction: GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gating Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-04 Yuan-ping Dong, Yun Wu, Yi-lu Zhao, Yu-min Chen, Tong-ye Liu, Yi-he Zhang, Jie-ying Xie, Jin-feng Zhang, Han Zhang, He Chen, Yu Peng, Chun-lei Zhang, Andrew R. Rau, Kasper B. Hansen, Hai-bing Xu, Feng Yi
-
New advances in small molecule drugs targeting NMDA receptors Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-04 Yue Zeng, Zhi-yan Qu, Qian-wen Zhu, Hai-ying Wang, Yu Zhou, Zhao-bing Gao
-
Formyl peptide receptor 2 is a potential biomarker and therapeutic target for inflammatory bowel disease Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Wen-sheng Yang, Xiao-zhen Wang, Wei Wu, Yuan Li, Guang-fei Wang, Qing-tong Zhou, Ming-Wei Wang, Zhi-ping Li
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is characterized by limited treatment options and a therapeutic ceiling. Failure to resolve inflammation is the key driver of disease progression. Formyl peptide receptor 2 (FPR2/ALX), a pivotal mediator of inflammation resolution, has emerged as a promising therapeutic target. In this study, we investigated
-
The mGluR2/3 agonist xanthurenic acid improves memory, attention, and synaptic deficits by modulating glutamate release in Alzheimer’s disease model Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Kyonghwan Choe, Jawad Ali, Hyun Young Park, Si Hoon Jang, Eun Yeong Choi, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim
-
Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamics Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Anna Åstrand, Emiliano Laudadio, Prince S. Gameli, Laura Martin, Jeremy Carlier, Francesco P. Busardò, Johan Dahlén, Xiongyu Wu, Peter Konradsson, Svante Vikingsson, Robert Kronstrand, Henrik Gréen
Synthetic cannabinoids (SC) target the human cannabinoid receptor 1 (hCB 1 ) and are extensively metabolized, but the metabolite activity on the hCB 1 receptor after a SC intake is largely unknown. In this study we compared the in vitro hCB 1 receptor activity of 26 metabolites of the synthetic cannabinoid receptor agonists (SCRA) JWH-018, AM-2201, THJ-018 and THJ-2201 as a model system for SC metabolite
-
Targeting virus-interacting host ion channels as a novel antiviral strategy Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Yu-yao Guo, Xiao-yi Mo, Jia-jing Wu, Chang Xie, Jing Yao
-
MS1-96 induces HIP1R-dependent PD-L1 degradation and promotes antitumor immunity in colorectal cancer Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Jin-jin Peng, Min Shao, Yu-yi Li, Jing Feng, Xin-tian Zhang, Che Xu, Qing-xin Xie, Wang-shuang Chen, Jia-qing Chen, Di Wu, Fang Bai, Han Yao, Yu-dao Shen, Xiang-jun Meng
-
Sino-C, a novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Yan-ming Zhang, Hui Lu, Bing-jie Xiao, Chun-cao Xu, Fan-fan Zhou, Ting Li, Zha-jun Zhan, Jin-jian Lu
-
Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-03 Lei Gong, Chang-xiao-feng Liu, Jian-hua Cheng, Jing Guo, Bin Li, Hong-yun Wang, Meng Liu, Jia-lin Wang, Xue-jing Li, Qiu-yue Fang, Zhao-yi Yi, Chu-zhong Li, Ya-zhuo Zhang, Wei-yan Xie
Dopamine receptor agonist (DA)-resistant prolactinoma presents a significant clinical challenge, highlighting the need for novel therapeutic strategies. Deguelin is a rotenoid compound derived from several plant species with unique antitumor effects. In this study we investigated the efficacy of deguelin on DA-resistant prolactinoma and elucidated its antitumor mechanisms. We showed that deguelin
-
Galangin 3-methyl ether alleviates mouse hypertrophic cardiomyopathy via targeting HDAC2 and subsequently inactivating the PI3K-AKT signaling pathway Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-01 Ke Zhang, Tao Xu, Xin-yu Heng, Jian-zhen Lei, De-shen Han, Shao-hong Huang, Mei-qi He, Lin Pu, Yue-yue Wu, Ning Sun, Hai Yang, Chao Ye
-
Targeting the 5-HT1B-YAP positive feedback loop protects against disturbed flow-induced atherogenesis in mice Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-11-01 Min-chun Jiang, Huan-yu Ding, Chak Kwong Cheng, Dong-qin Cai, Hai-xia Guan, Jian Kuang, Ronald Ching Wan Ma, Yin Xia, Xiao-qiang Yao, Li Wang, Yu Huang
-
Lung memory B cells ameliorate Alzheimer’s disease-like pathology in 5×FAD mice through the CXCL12-CXCR4 axis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-17 Yan-li Zhang, Shi-xin Ding, Min Cao, Shu-ying Zhang, Yue Li, Ze Wang, Yu-xi Jin, Si-jia Chen, Yi-miao Wang, Charles Marshall, Jing-ping Shi, Jun-ying Gao, Wei-xi Feng, Yin Cao, Ming Xiao, Gang Hu
Although most AD-related pathological studies are limited to the brain, increasing evidence has demonstrated the contribution of peripheral immune cells to the pathogenesis of AD. We recently demonstrated that meningeal B cells inhibit β-amyloid (Aβ) production in the frontal cortex of young 5×FAD mice. In this study, we explored the precise origin of meningeal B cells. We observed that the AD-like
-
Zinc pyrithione functions as a small-molecule STING agonist to exert antitumor immunotherapy effects Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-17 Man Zhao, Zu-yi Jin, Wei-zhen Fan, Peng-fei Qiang, Zhi-hua Zheng, Guo-feng Li, Liang Hong, Min Li
The stimulator of interferon genes (STING) is a crucial pattern recognition receptor that activates innate immunity, particularly in response to pathogen infection and various stimuli. Notably, activation of STING exhibits remarkable potential in enhancing anti-tumor immunity, underscoring the significance of discovering STING small molecule agonists. Recently, zinc pyrithione (ZPT), a marketed antifungal
-
Inhibiting mPGES-2 impedes renal cyst growth in mice with polycystic kidney disease Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-17 Dan-dan Zhong, Cheng Hu, Lan-lan Zhao, Yan Shen, Ru-meng Zhang, Ying Liu, Bu-hui Liu, Wen Su, Bao-xue Yang, Hui Xiong, Dong Guo, Dong Sun, Ying-ying Zou, Ying Sun
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development of multiple fluid-filled cysts in the kidneys, resulting in progressive decline and failure of renal function. Microsomal prostaglandin E synthase-2 (mPGES-2) is a unique bifunctional enzyme that catalyzes the conversion of prostaglandin H2 (PGH2) to prostaglandin E2 (PGE2) or to malondialdehyde (MDA) in conjunction
-
An engineered IL-21 variant is a potent antitumor candidate for antitumor immunotherapy Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-17 Hui Wu, Ya-ping Cheng, Yu-long Liu, Ruo-han Zhu, Li-wen Ji, Ming-kai Wang, Quan-xiao Li, Zhao-ling Shen, Tian-lei Ying, Yan-ling Wu
IL-21, as an immune agonist, has demonstrated limited therapeutic efficacy in cancer immunotherapy. To overcome this inherent limitation, we constructed a yeast surface-displayed IL-21 mutant library guided by the structure of the IL-21/IL-21 receptor (IL-21R). Following one round of magnetic bead sorting and three rounds of fluorescence-activated cell sorting, several variants were isolated and evaluated
-
Nobiletin and polydatin synergistically alleviate triple-negative breast cancer liver metastasis via suppressing ECM1a-mediated fatty acid biosynthesis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-13 Jue Wang, Wei-wei Liu, Qiong-lian Huang, Han-juan Ning, Jian-yi Wang, Xiang-hui Han
Breast cancer liver metastasis (BCLM) is characterized by high incidence and poor prognosis, lacking effective therapeutic strategies. Recent evidence suggests that lipid metabolic reprogramming plays an important role in the initiation and development of BC metastasis. In clinical practice of traditional Chinese medicine, Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. (CR) herb pair is used
-
Retraction Note: Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2 Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-09 Yan-tao Han, Xue-hong Chen, Hui Gao, Jun-li Ye, Chun-bo Wang
-
Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-09 Yu-qi Chen, Jun-rui Ye, Sha-sha Wang, Ye Peng, Run Zhou, Ruo-lan Yuan, Wen-fei Wang, Shi-feng Chu, Zhao Zhang, Nai-hong Chen
Selective serotonin reuptake inhibitors (SSRIs) are characterized by delayed therapeutic onset largely due to their reliance on the desensitization of 5-HT1A autoreceptors (5-HT1ARautos) within the dorsal raphe nucleus (DRN). It has been shown that dissociation of serotonin transporter (SERT) and neuronal nitric oxide synthase (nNOS) interaction selectively modulates 5-HT1ARautos, thereby facilitating
-
Targeting the interactions between neutrophils and microglia: a novel strategy for anti-inflammatory treatment of stroke Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Long-rui Wang, Zi-yuan Zhao, Zhao-wei Li, Yin-ru Jiang, Wen-jing Sun, Guan-hua Du, Rui-li Shi, Ling-lei Kong
Stroke is the second leading cause of mortality and the leading cause of adult disability worldwide. Neuroinflammation is a crucial mechanism that regulates the pathogenesis and prognosis of stroke and involves both peripheral and intracerebral immune cells. Neutrophils and microglia are the primary immune cells that mediate neuroinflammation and play bidirectional roles after stroke. Significant interactions
-
A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Hao Zhang, Ya-nan Huo, Ya-wei Zhang, Zhi-feng Cheng, Xiao-jing Wang, Jun Chen, Qi-fu Li, Xin-hua Xiao, Li-zhen Lan, Xin-long Ma, Liu-jun Fu, Xiao-pan Chen, Ling-qing Yuan, Fang-jiang Xu, Li You, Jin-luo Cheng, Dun Hong, Fei Hua, Li Mao, Guo-xi Jin, Guan-feng Yao, Ya-jun Bing, Gui-jie Xie, Ying Yang, Jin Xu, Ying Zhang, Wei Zhang, Yue Ding, Guo-ping Cai, Hui-min Zhou, Cheng-yun Liu, Jian-xiang Zhang
To date, monthly oral bisphosphonates have not been available in China. In this randomized, double blind, positive-controlled, multicenter phase III clinical trial, we compared the efficacy and safety of monthly minodronate versus weekly alendronate in the treatment of Chinese postmenopausal women with osteoporosis. A total of 548 participants were screened across 31 study centers, of which 330 participants
-
Harnessing deep statistical potential for biophysical scoring of protein-peptide interactions Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 De-jun Jiang, Hui-feng Zhao, Hong-yan Du, Yu Kang, Pei-chen Pan, Zhen-xing Wu, Yun-dian Zeng, O-din Zhang, Xiao-rui Wang, Ji-ke Wang, Yuan-sheng Huang, Yi-hao Zhao, Chang-Yu Hsieh, Dong-sheng Cao, Hui-yong Sun, Ting-jun Hou
Protein-peptide interactions (PpIs) play a critical role in major cellular processes. Recently, a number of machine learning (ML)-based methods have been developed to predict PpIs, but most of them rely heavily on sequence data, limiting their ability to capture the generalized molecular interactions in three-dimensional (3D) space, which is crucial for understanding protein-peptide binding mechanisms
-
ROS-induced degradation of hERG potassium channels contributes to aripiprazole-induced prolongation of the QTc interval Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Yu-hong Cao, Xiao-chen Wang, Hong-kun Wang, Zong-kuai Yang, Dan-dan Liu, Yang Yang, Rong Kuang, Ping Liang
As antipsychotic administration often persists for a lifetime, antipsychotic-induced cardiotoxicity (AIC) becomes a significant and potentially life-threatening side effect. Owing to the lack of an appropriate human cardiomyocyte experimental model, current research on AIC is primarily based on clinical case reports. In this study, we generated human iPSC-derived cardiomyocytes (iPSC-CMs) and characterized
-
PXR ribosylation at E194 amplifies NAPQI in acetaminophen‒induced liver injury in mice, rescued by Schisandrin B Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Jia-chan Long, Chen-xu Liu, Meng-yao Wang, Cai-hong Liu, Fan Zhang, Zhong-qiu Liu, Lin An, Cai-yan Wang
Acetaminophen (APAP)-induced acute liver injury (AILI) is primarily driven by CYP3A4‒mediated overproduction of the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI), CYP3A4 activity serves as the rate-limiting determinant of NAPQI accumulation levels. Poly ADP-ribose polymerase 1 (PARP1)-driven ribosylation, a posttranslational modification, has been linked to drug-induced liver injury. PARP1
-
Discovery and characterization of a novel HIF-2α agonist for the treatment of CKD-related renal anemia Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Shu-qing Chu, Yi-jie Chen, Rui-rui Yang, Dan Teng, Gui-zhen Zhou, Ying-ying Zhang, Bu-ying Niu, Jia-hang Xu, Ke-xin Lin, Xin-yu Yang, Xu-tong Li, Ming-yue Zheng, Su-lin Zhang
Hypoxia-inducible factor 2-alpha (HIF-2α), a critical transcription factor, forms a heterodimer with aryl hydrocarbon receptor nuclear translocator (ARNT) to drive the transcription of erythropoietin (EPO), a key regulator of erythropoiesis. Activation of this pathway plays a pivotal role in the treatment of anemia. By discovered structure-based virtual screening and pharmacological assays, we herein
-
HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-10-01 Wen-xin Zhang, Ting He, Kun Fang, Ying-lei Gao, Yi-ming Sun, Fa-jun Nan, Jian Ding, Yi Chen, Yan-fen Fang
Histone deacetylases (HDAC) inhibition represents one of the few validated strategies in epigenetic cancer therapies, demonstrating significant clinical efficacy in T-cell lymphomas and multiple myeloma, yet exhibiting limited efficacy against solid tumors. GCJ-490A is a novel HDAC inhibitor discovered by medicinal chemists in our institute, which exhibits potent in vitro and in vivo anticancer activity
-
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-29 Christian D. Mitchell, Carol A. Morris, Melissa Wild, Ashlynn Cunningham, Piyanan Chuesiang, Aya A. Mohammed, Bolni Marius Nagalo, Nancy J. Rusch, Abdelrahman Y. Fouda, Esraa Shosha
Pathological retinal neovascularization (NV) contributes to vision loss in diabetic retinopathy (DR) and retinopathy of prematurity, which are the leading causes of blindness in working-age adults and children, respectively. Retinal hypoxia is a key driver of pathological neovascularization that results in uncontrolled vessel sprouting and the formation of immature and leaky blood vessels. Anti-vascular
-
Editorial Expression of Concern: n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2α and telomerase activity Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-22 Chyou-wei Wei, Chai-ching Lin, Yung-luen Yu, Chai-yi Lin, Po-cheng Lin, Min-tze Wu, Cheng-jueng Chen, Wen-liang Chang, Shinn-zong Lin, Yi-lin Sophia Chen, Horng-jyh Harn
-
TNFSF15 alleviates myeloid-derived suppressor cell-mediated cancer immunosuppression in mice Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-19 Yi-pan Zhu, Jing Sun, Xin-yu Cao, Xin-yu Ding, Yu-ying Wang, Qiu-ju Han, Jing-ying Wang, Lu-yuan Li, Zhi-song Zhang
Myeloid-derived suppressor cells (MDSCs) are a category of immature myeloid cells that have an important function in suppressing immune responses in a variety of pathological settings. Thus, MDSCs are the subject of intensive studies regarding their recruitment, expulsion, deactivation, and maturation promotion. Tumor necrosis factor superfamily member 15 (TNFSF15) is produced largely by vascular endothelial
-
Correction: magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-18 Yan-zi Yang, Xiao-juan Zhao, Hong-jiang Xu, Shan-chun Wang, Ying Pan, Shui-juan Wang, Qiang Xu, Rui-qing Jiao, Hong-mei Gu, Ling-dong Kong
-
Species differences in the hepatobiliary disposition of morphine-6-glucuronide mediated by hepatic transporters in rats and humans Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-15 Zi-tao Guo, Hong Wang, Ning-jie Xie, Yu-fan Zhou, Meng-lin Zhang, Xin-yao Kang, Jue Wang, Qing Zhu, Xiao-yan Chen
-
Fumarate hydratase ameliorates pressure overload induced cardiac remodeling by controlling Elovl7-mediated biosynthesis of unsaturated fatty acids Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-12 Lan-lan Li, Chao-jun Sun, Xiao-tong Mo, Yun Xing, Tong Zhang, Heng Zhang, Nan Zhao, Xiao-feng Zeng, Sha-sha Wang, Yan-yan Meng, Sai-yang Xie, Wei Deng
-
Tigecycline suppresses colon cancer stem cells and impairs tumor engraftment by targeting SNAI1-regulated epithelial-mesenchymal transition Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-12 Antonio Jesús Ruiz-Malagón, María Jesús Rodríguez-Sojo, Jorge García-García, Ailec Ho-Plagaro, Federico García, Teresa Vezza, Eduardo Redondo-Cerezo, Carmen Griñán-Lisón, Juan Antonio Marchal, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Julio Gálvez
-
Krüppel-like factor 15 ameliorates alcohol-induced liver injury in mice via regulation of the PFKFB3/AKT axis Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-11 Hao Chen, Lin Yang, Xiao-feng Li, Si-yuan Han, Qi Zhao, Rong-cheng Xiao, Zi-yao Ou, Ling Fang, Yan Du
-
HER3 upregulation reduces DS-8201 sensitivity in HER2-positive tumor cells by ATR/CHK1/FoxO1 signaling cascade Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-10 Wen-jing Li, Kai-ge Kang, Yu-xiang Zhang, Xin-xin Zhao, Xi Zhu, Jiao Tang, Yong-peng Li, Hao-yu Fu, Qing Yao, Lei Wang, Li-guang Lou
-
Antiemetic drug fosaprepitant exerts anti-tumor effects against NSCLC by targeting FAK to inhibit AKT and JNK/c-Jun pathways Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-10 Ying Wang, Yu-na Shao, Chen-kang Ma, Chen-ying Shu, Yi-hua Zhang, Di Lu, Hui-ling Zhang, Jian-jie Zhu, Yuan-yuan Zeng, Jian-jun Li, Zhao-wei Yan, Ze-yi Liu
-
GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gating Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-10 Yuan-ping Dong, Yun Wu, Yi-lu Zhao, Yu-min Chen, Tong-ye Liu, Yi-he Zhang, Jie-ying Xie, Jin-feng Zhang, Han Zhang, He Chen, Yu Peng, Chun-lei Zhang, Andrew R. Rau, Kasper B. Hansen, Hai-bing Xu, Feng Yi
-
Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-09 You-ping Jin, Bu-jie Xu, Xiu-fen Zhang, Xue Wang, Li Wang, Lu-ying Li, Shu-yi Chen, Ping Zhu, Xiu-ling Zhi, Lei Lv, Chao-fu Wang, Zheng-lin Wang, Yang-bai Sun, Ping Zhou
-
Salvianolic acid A from Salvia miltiorrhiza identified as a cap-dependent endonuclease inhibitor for pathogenic arenaviruses Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-03 Xiao Gao, Yan Wu, Xiao-xue He, Guo-long Liu, Hai-xia Yang, Jia Lu, Xue-rui Zhu, Xin-lan Chen, Chen-shu Zhao, Hao-yu Li, Zhong-fa Zhang, Chan Yang, Shu Shen, Fei Deng, Wei Xu, Shu-wen Liu, Geng-fu Xiao, Xiao-yan Pan
-
Sirtuin 6 mitigates thoracic aortic aneurysm progression via maintenance of mitochondria homeostasis in vascular smooth muscle cells Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-02 Xiao-ting Yu, Nan Zhao, Yu-tao Ma, Jin-meng Jia, Yan-ting Song, Xiao-yan Liu, Yao Xiao, Bo Jia, Guang-ming Li, Jin-han He, Sheng Wang, Jun-ming Zhu, Frank J. Gonzalez, Ai-juan Qu
-
BMP1 inhibitor UK383367 improves MI-induced cardiac remodeling and fibrosis in mice via ameliorating macrophage polarization and mitochondrial dysfunction Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-02 Cheng-hu Guo, Qian-qian Wang, Jia-qi Li, Wei Ji, Lin Chen, Mei-ling Chang, Lian-yue Ma, Xiao-ling Liu, Mei Ni
-
Selective recognition memory impairment in mitochondrial hydroxylase Clk1 mutant mice, rescued by antipsychotics Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-01 Zhi-feng Shi, Zhe-xiang Yu, Ling-han Gu, Zhi-xue Ma, Qin-bo Chen, Li-bin Wen, John L. Waddington, Xue-chu Zhen
-
PDE4 inhibitor apremilast ameliorates TNBS-induced irritable bowel syndrome in mice by activating the Nrf-2 signaling pathway in enteric glial cells Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-01 Yu-hao Lu, Shu-yue Lei, Tao Yang, You-sheng Xu, Hong-lin Wang, Chun-lan Feng, Wei Tang
-
SOCS1 depletion drives osteosarcoma stemness and chemoresistance by suppressing ACTN4 degradation Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-09-01 Jin-yan Feng, Xian-fu Wei, Long Chen, Hou-zhi Yang, Yi-qin Li, Jin-wu Wang, Yong-heng Liu, Yao Xu, Qing-qian Zhao, Pu Li, Xiao-dong Zhang, Guo-wen Wang, Xiu-xin Han
-
Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-28 San-shan Jin, Heng Zhang, Jia-hui Yan, Can-rong Wu, Xiao-qing Cai, Kai Wu, Ming-Wei Wang, H. Eric Xu, De-hua Yang, Yi Jiang
-
AI-enhanced virtual screening approach to hit identification for GluN1/GluN3A NMDA receptor Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-26 Yue-shan Ji, Yue Zeng, Shao-fei Hu, Shu-wang Li, Bei-chen Zhang, Chang Liu, Hao-chen Wu, An-yang Wang, Zhao-bing Gao, Yue Kong
-
Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-22 Yi-min Gu, Qing-ning Yuan, Xin Li, Qian He, H. Eric Xu, Li-hua Zhao
-
Isoliensinine inhibits mitophagy and sensitizes T cell malignancies for STING-mediated NK clearance Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-21 Xiao Ge, Guang-ming Yang, Xiao-long Zhang, Jing Cao, Ying-jie Qing, San-bing Shen, Yang Pan, Po Hu
-
ALKBH5 deficiency suppresses hepatocarcinogenesis in mice via m6A-dependent STAT1 restoration Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-21 Kai-ting Wang, Shuai Yang, Zi-han Zhao, Chun-hua Rui, Si-yun Shen, Dan Cao, Lin-na Guo, Shan-hua Tang, Lei Chen, Hong-yang Wang, Xin-yao Qiu
-
DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I/MDA5-MAVS to enhance antitumor immunity Acta Pharmacol. Sin. (IF 8.4) Pub Date : 2025-08-19 Yao Tu, Qing-yun Zhu, Wen-jun Huang, Sha Feng, Yu-ling Tan, Lu-lu Li, Xin-tong Xie, Qin-yuan Li, Shou-hui Huang, Cheng-zhou Mao, Bi-zhu Chu, Yu-yang Jiang




















































京公网安备 11010802027423号